1.
Visentin A, Trentin L. Response to ‚ÄúCardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients‚ÄĚ. Haematologica; https://doi.org/10.3324/haematol.2021.280199 [Early view].